0 followers
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Ann Leen
Kura Oncology
20 followers
Dyne Therapeutics
3 followers
Precigen
3 followers
Arcturus Therapeutics
2 followers
Biocytogen
2 followers
Gamida Cell
2 followers
Fortis Life Sciences
1 follower
Entrada Therapeutics
1 follower
Cabaletta Bio
1 follower
Janux Therapeutics
1 follower
Matica Biotechnology
1 follower
Explore companies